You searched for "cystic"
Macular holes: A brief review
1 August 2017
| Sidath Wijetilleka, Roger McPherson
|
EYE - Vitreo-Retinal
The classification of macular holes has been modernised by OCT findings. This is a brief review and encompasses the historical literature on macular holes. A macular hole is an anatomical discontinuation of the neurosensory retina at the centre of the...
The management of possibly progressive pterygium
1 February 2015
| Amit Patel, Peter McDonnell, M Quinlan
|
EYE - Cornea
A 43-year-old Sudanese male patient is referred by his GP with a fleshy lesion encroaching the nasal cornea for the last six months. History Make note of: risk factors, i.e. UV exposure and ocular irritation - history of living in...
A pituitary tumour from 1927
The author shares a clinical case from Edinburgh Royal Infirmary’s archives. It is not often in the course of a clinical career that one gets the opportunity to review a patient who had been treated by a pioneer neurosurgeon some...Crystalline keratopathy in monoclonal gammopathy of undetermined significance
2 April 2025
| Kar Yen Phoong
|
EYE - Cornea
Monoclonal gammopathies encompass a group of plasma cell disorders characterised by the excessive production of abnormal monoclonal immunoglobulins in the bloodstream [1]. This category includes multiple myeloma, monoclonal gammopathy of undetermined significance (MGUS), amyloidosis and other lymphoproliferative disorders. Monoclonal gammopathy...
Type 3 macular neovascularisation (MNV) due to age-related macular degeneration
3 October 2024
| Sofia Rokerya
|
EYE - Vitreo-Retinal
This paper systematically reviews and summarises the current knowledge on type 3 neovascularisation due to age-related macular degeneration which is defined as neovascularisation originating from the retinal deep capillary plexus that grows towards the outer retina often penetrating the level...
Sensitive cilia – eyelashes in health and disease
5 October 2020
| Jonathan CP Roos, Rachna Murthy
|
EYE - Cornea, EYE - Orbit, EYE - Oculoplastic, EYE - General
In health our eyelashes protect the eyes, but in disease they can disfigure, impair quality of life and threaten vision. In this review the authors discuss aspects of lashes that are relevant to all professionals working near the eyes and...
Orbital abscess following posterior subtenon steroid injection
The authors report a case of orbital cellulitis following posterior subtenon injection of triamcinolone acetonide. A 57-year-old male patient with a background of complicated cataract surgery underwent vitrectomy with explantation of dislocated intraocular lens and insertion of anterior chamber lens....
Ranibizumab for the treatment of age-related macular degeneration
1 April 2015
| Nana Theodorou
|
EYE - Vitreo-Retinal
This multicentre randomised prospective open label study compared 0.5 versus 2mg of ranibizumab in patients with submacular retinal pigment epithelial (RPE) detachment due to age-related macular degeneration. Four treatment regimens were used for the two strengths either monthly for 12...
Correlation between anti-retinal antibodies and proliferative vitreoretinopathy (PVR)
1 October 2018
| Kurt Spiteri Cornish
|
EYE - Vitreo-Retinal
The pathological basis of PVR is not clearly understood and there are no effective medications targeting this condition. This cross-sectional study looked at the possible association of anti-retinal antibodies with patients with PVR and retinal detachment (RD). Aqueous and vitreous...
Smoking and Behçet’s disease
1 October 2015
| Saruban Pasu
|
EYE - Vitreo-Retinal
This study aimed to investigate the relationship between smoking and prognosis of ocular Behçet’s disease (BD). Records of 202 patients with ocular features of BD were reviewed from a Turkish hospital. Patients were divided into two groups according to their...
Diclofenac versus Bromfenac after cataract surgery
1 April 2019
| Kurt Spiteri Cornish
|
EYE - Cataract, EYE - Refractive
|
Non-steroidal anti-inflammatory drugs, bromfenac, cataract surgery, diclofenac, intraocular inflammation
Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used after cataract surgery to reduce inflammation and cystoid macular oedema (CMO). Diclofenac 0.1% is used three to five times daily for 28 days and Bromfenac 0.09% twice daily for 14 days postoperatively. The...
Cystoid macular oedema following cataract surgery
1 October 2019
| Ivan Yip
|
EYE - Cataract, EYE - Refractive
|
NSAIDs, cataract, cataract surgery, corticosteroids, cystoid macular oedema
This review covers the history, incidence, diagnosis, risk factors, pathophysiology and medical management of postoperative macular oedema (PCMO), with a particular emphasis on key contemporary studies and novel observations. The authors revisit the incidence of well-established risk factors including intraoperative...
